Glen Eagle Advisors, LLC Incyte Corp Transaction History
Glen Eagle Advisors, LLC
- $546 Billion
- Q2 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Incyte Corp stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 75 shares of INCY stock, worth $6,175. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75
Previous 124
39.52%
Holding current value
$6,175
Previous $10.3 Million
56.0%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding INCY
# of Institutions
625Shares Held
198MCall Options Held
763KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.53 Billion24.77% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.76 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.68 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$1.26 Billion0.58% of portfolio
-
State Street Corp Boston, MA10.9MShares$894 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $18.3B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...